New Technology Leads to Breakthrough in Metformin Mechanism of Action
Jun 23, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Jacob Roberts, PharmD Candidate 2021 of University of Colorado Denver Skaggs School of Pharmacy and Pharmaceutical Sciences
A new study shows that metformin may have a previously unknown mechanism of action that could lead to new and improved diabetes medications.
Kobe University Graduate School of Medicine's Professor Ogawa Wataru (the Division of Diabetes and Endocrinology) and Project Associate Professor Nogami Munenobu (the Department of Radiology) came together to utilize a newer form of imaging to study metformin's mechanism of action. A new bio-imaging apparatus, called the PET-MRI, has improved researchers' abilities to look at bodily structures that were not previously observable....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.